STOCK TITAN

[Form 4] MetLife, Inc. Insider Trading Activity

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
4
Rhea-AI Filing Summary

MetLife, Inc. (MET) filed a Form 4 reporting routine insider activity by non-management director Carlos M. Gutierrez. On 06/17/2025, Gutierrez received 562 shares of common stock (transaction code A) at a stated price of $0, reflecting the company’s policy to pay a portion of director retainers in equity. Following the grant, the director now owns 23,851 shares directly and 18,807 shares indirectly through the Carlos M. Gutierrez Trust. No derivative securities were involved, and the filing contains no sales or dispositions.

MetLife, Inc. (MET) ha presentato un Modulo 4 che segnala un'attività interna di routine da parte del direttore non esecutivo Carlos M. Gutierrez. Il 17/06/2025, Gutierrez ha ricevuto 562 azioni ordinarie (codice transazione A) a un prezzo dichiarato di $0, in linea con la politica aziendale di corrispondere una parte dei compensi dei direttori in azioni. Dopo questa assegnazione, il direttore possiede ora 23.851 azioni direttamente e 18.807 azioni indirettamente tramite il Carlos M. Gutierrez Trust. Non sono stati coinvolti strumenti derivati e la comunicazione non riporta vendite o cessioni.

MetLife, Inc. (MET) presentó un Formulario 4 informando sobre una actividad rutinaria de un director externo, Carlos M. Gutierrez. El 17/06/2025, Gutierrez recibió 562 acciones ordinarias (código de transacción A) a un precio declarado de $0, reflejando la política de la empresa de pagar una parte de la remuneración de los directores en acciones. Tras esta concesión, el director posee ahora 23,851 acciones directamente y 18,807 acciones indirectamente a través del Carlos M. Gutierrez Trust. No se involucraron valores derivados y el informe no contiene ventas ni disposiciones.

MetLife, Inc. (MET)는 비경영 이사 Carlos M. Gutierrez의 일상적인 내부자 거래 활동을 보고하는 Form 4를 제출했습니다. 2025년 6월 17일, Gutierrez는 회사 정책에 따라 이사 보수의 일부를 주식으로 지급받아 562주의 보통주(거래 코드 A)를 $0의 명시된 가격으로 받았습니다. 이번 부여 후, 이사는 직접 23,851주Carlos M. Gutierrez Trust를 통해 간접적으로 18,807주를 보유하게 되었습니다. 파생 증권은 포함되지 않았으며, 제출서에는 매도나 처분 사항이 없습니다.

MetLife, Inc. (MET) a déposé un formulaire 4 rapportant une activité interne de routine par le directeur non exécutif Carlos M. Gutierrez. Le 17/06/2025, Gutierrez a reçu 562 actions ordinaires (code de transaction A) à un prix déclaré de 0 $, reflétant la politique de l'entreprise de verser une partie des honoraires des administrateurs en actions. Suite à cette attribution, le directeur détient désormais 23 851 actions en direct et 18 807 actions indirectement via le Carlos M. Gutierrez Trust. Aucun instrument dérivé n’a été impliqué et le dépôt ne contient aucune vente ni disposition.

MetLife, Inc. (MET) hat ein Formular 4 eingereicht, das routinemäßige Insideraktivitäten des nicht geschäftsführenden Direktors Carlos M. Gutierrez meldet. Am 17.06.2025 erhielt Gutierrez 562 Stammaktien (Transaktionscode A) zu einem angegebenen Preis von 0 $, was die Unternehmenspolitik widerspiegelt, einen Teil der Direktorenvergütung in Aktien zu zahlen. Nach der Zuteilung besitzt der Direktor nun 23.851 Aktien direkt und 18.807 Aktien indirekt über den Carlos M. Gutierrez Trust. Es waren keine Derivate beteiligt, und die Meldung enthält keine Verkäufe oder Veräußerungen.

Positive
  • None.
Negative
  • None.

Insights

TL;DR: Routine equity grant; immaterial to MET’s valuation.

This Form 4 reflects a standard director retainer paid in stock—562 shares worth roughly mid-four figures at current prices. The grant modestly increases insider alignment but is far too small to affect float, earnings, or governance risk. No red flags: no sales, no derivatives, no 10b5-1 plan disclosures. Investors should view the filing as an administrative update rather than a signal of strategic intent.

MetLife, Inc. (MET) ha presentato un Modulo 4 che segnala un'attività interna di routine da parte del direttore non esecutivo Carlos M. Gutierrez. Il 17/06/2025, Gutierrez ha ricevuto 562 azioni ordinarie (codice transazione A) a un prezzo dichiarato di $0, in linea con la politica aziendale di corrispondere una parte dei compensi dei direttori in azioni. Dopo questa assegnazione, il direttore possiede ora 23.851 azioni direttamente e 18.807 azioni indirettamente tramite il Carlos M. Gutierrez Trust. Non sono stati coinvolti strumenti derivati e la comunicazione non riporta vendite o cessioni.

MetLife, Inc. (MET) presentó un Formulario 4 informando sobre una actividad rutinaria de un director externo, Carlos M. Gutierrez. El 17/06/2025, Gutierrez recibió 562 acciones ordinarias (código de transacción A) a un precio declarado de $0, reflejando la política de la empresa de pagar una parte de la remuneración de los directores en acciones. Tras esta concesión, el director posee ahora 23,851 acciones directamente y 18,807 acciones indirectamente a través del Carlos M. Gutierrez Trust. No se involucraron valores derivados y el informe no contiene ventas ni disposiciones.

MetLife, Inc. (MET)는 비경영 이사 Carlos M. Gutierrez의 일상적인 내부자 거래 활동을 보고하는 Form 4를 제출했습니다. 2025년 6월 17일, Gutierrez는 회사 정책에 따라 이사 보수의 일부를 주식으로 지급받아 562주의 보통주(거래 코드 A)를 $0의 명시된 가격으로 받았습니다. 이번 부여 후, 이사는 직접 23,851주Carlos M. Gutierrez Trust를 통해 간접적으로 18,807주를 보유하게 되었습니다. 파생 증권은 포함되지 않았으며, 제출서에는 매도나 처분 사항이 없습니다.

MetLife, Inc. (MET) a déposé un formulaire 4 rapportant une activité interne de routine par le directeur non exécutif Carlos M. Gutierrez. Le 17/06/2025, Gutierrez a reçu 562 actions ordinaires (code de transaction A) à un prix déclaré de 0 $, reflétant la politique de l'entreprise de verser une partie des honoraires des administrateurs en actions. Suite à cette attribution, le directeur détient désormais 23 851 actions en direct et 18 807 actions indirectement via le Carlos M. Gutierrez Trust. Aucun instrument dérivé n’a été impliqué et le dépôt ne contient aucune vente ni disposition.

MetLife, Inc. (MET) hat ein Formular 4 eingereicht, das routinemäßige Insideraktivitäten des nicht geschäftsführenden Direktors Carlos M. Gutierrez meldet. Am 17.06.2025 erhielt Gutierrez 562 Stammaktien (Transaktionscode A) zu einem angegebenen Preis von 0 $, was die Unternehmenspolitik widerspiegelt, einen Teil der Direktorenvergütung in Aktien zu zahlen. Nach der Zuteilung besitzt der Direktor nun 23.851 Aktien direkt und 18.807 Aktien indirekt über den Carlos M. Gutierrez Trust. Es waren keine Derivate beteiligt, und die Meldung enthält keine Verkäufe oder Veräußerungen.

SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
GUTIERREZ CARLOS M

(Last) (First) (Middle)
METLIFE, INC.
200 PARK AVENUE

(Street)
NEW YORK NY 10166

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
METLIFE INC [ MET ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
X Director 10% Owner
Officer (give title below) Other (specify below)
3. Date of Earliest Transaction (Month/Day/Year)
06/17/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 06/17/2025 A(1) 562 A $0 23,851 D
Common Stock 18,807 I by Carlos M. Gutierrez Trust
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Explanation of Responses:
1. MetLife, Inc.'s non-management director compensation arrangements pay a portion of non-management director retainer fees in MetLife, Inc. common stock.
Remarks:
/s/ Morgan Mayes, Authorized Signer 06/20/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

How many MetLife (MET) shares did Director Carlos M. Gutierrez acquire?

He was granted 562 common shares under the director compensation plan.

What is the transaction code listed in the Form 4 for MET?

The filing shows code A, indicating an acquisition from the company—specifically a compensation award.

What are Gutierrez’s total MetLife holdings after the transaction?

He now holds 23,851 shares directly and 18,807 shares indirectly via a trust.

On what date did the share acquisition occur?

The transaction date reported is June 17, 2025.

Does the Form 4 include any derivative security activity?

No. Table II is blank, indicating no derivatives were acquired or disposed.
MetLife

NYSE:MET

MET Rankings

MET Latest News

MET Latest SEC Filings

MET Stock Data

52.61B
560.14M
16.51%
76.26%
1.08%
Insurance - Life
Life Insurance
Link
United States
NEW YORK